Abstract:Biodegradable polymer-based therapeutics have recently become essential drug delivery biomaterials for various bioactive compounds. Biodegradable and biocompatible polymer-based biomaterials fulfill the requirements of these therapeutics because they enable to obtain polymer biomaterials with optimized blood circulation, pharmacokinetics, biodegradability, and renal excretion. Herein, we describe an adaptable polymerization platform employed for the synthesis of long-circulating, stimulus-sensitive and biodegradable biomaterials, therapeutics, or theranostics. Four chain transfer agents (CTA) were designed and successfully synthesized for the reversible addition-fragmentation chain transfer polymerization, allowing the straightforward synthesis of hydrolytically biodegradable structures of block copolymers-based biomaterials. The controlled polymerization using the CTAs enables controlling the half-life of the hydrolytic degradation of polymer precursors in a wide range from 5 h to 21 days. Moreover, the antitumor drug pirarubicin (THP) was successfully conjugated to the polymer biomaterials via a pH-sensitive hydrazone bond for in vitro and in vivo experiments. Polymer conjugates demonstrated superior antitumor efficacy compared to basic linear polymer-based conjugates. Notably, the biodegradable systems, even though those with degradation in the order of hours were selected, increased the half-life of THP in the bloodstream almost two-fold. Indeed, the presented platform design enables the main chain-end specific attachment of targeting ligands or diagnostic molecules. The adaptable polymerization platform design allows tuning of the biodegradability rate, stimuli-sensitive drug bonding, and optimized pharmacokinetics to increase the therapy outcome and system targeting, thus allowing the preparation of targeted or theranostic polymer conjugates. STATEMENT OF SIGNIFICANCE: Biodegradable and biocompatible polymer-based biomaterials are recognized as potential future bioactive nanomedicines. To advance the development of such biomaterials, we developed polymerization platforms utilizing tailored chain transfer agents allowing the straightforward synthesis of hydrolytically degradable polymer biomaterials with tuned biodegradability from hours to several days. The platform allows for the synthesis of long-circulating, stimulus-sensitive and biodegradable biomaterial serving as drug carriers or theranostics. The therapeutic potential was validated by preparation of polymer biomaterials containing pirarubicin, anticancer drug, bound via pH sensitive bond and by showing prolonged blood circulation and increased antitumor activity while keeping the drug side effects low. This work paves the way for future development of biodegradable polymer biomaterials with advanced properties in drug delivery.

Tuning polymer-blood and polymer-cytoplasm membrane interactions by manipulating the architecture of poly(2-oxazoline) triblock copolymers

Novel Amphiphilic, Biodegradable, Biocompatible, Cross-Linkable Copolymers: Synthesis, Characterization and Drug Delivery Applications

Length Control of Biodegradable Fiber-Like Micelles Via Tuning Solubility: A Self-Seeding Crystallization-Driven Self-Assembly of Poly(-caprolactone)-Containing Triblock Copolymers

Telechelic Triblock Poly(α‐Amino Acid)‐Poly(Tetrahydrofuran)‐Poly(α‐Amino Acid) Copolymers: Chain‐End Transformation, Polymerization and Ph‐responsive Hydrolysis†

Synthesis and Properties of Polypeptoid‐containing Block Copolymers: A Review

Synthesis and Thermoresponsive Properties of Biocompatible and Biodegradable Triblock Copolymers Bearing Linear or Y-Shaped OEG Pendants

Block Polypeptoids: Synthesis, Characterization, and Response Toward Irradiation with UV Light and Temperature

Adaptable polymerization platform for therapeutics with tunable biodegradability

Bioinspired zwitterionic triblock copolymers designed for colloidal drug delivery: 1 — Synthesis and characterization

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

A Single Enzyme Mediates the “Quasi-Living” Formation of Multiblock Copolymers with a Broad Biomedical Potential

Solid-Phase Synthesis as a Tool to Create Exactly Defined, Branched Polymer Vectors for Cell Membrane Targeting

Highly Effective Synthetic Polymer-Based Blockers of Non-Specific Interactions in Immunochemical Analyses

Biocompatibility of Thermo‐responsive PNIPAAm‐PLLA‐PNIPAAm Triblock Copolymer As Potential Drug Carrier

Poly(2-isopropenyl-2-oxazoline) as a Versatile Functional Polymer for Biomedical Applications

Synthesis of Temperature-Responsive Heterobifunctional Block Copolymers of Poly(Ethylene Glycol) and Poly(N-Isopropylacrylamide)

Novel Triblock Copolymers Comprising A Polyrotaxane Middle Block Flanked by Pnipaam Blocks Showing Both Thermo- and Solvent-Response

Novel Amphiphilic Block Copolymers Enhancing Osteoblast Attachment and Growth

Self-assembled nanoparticles of PEG and poly(2-oxazoline) based lactide block copolymers

Synthesis, Self-Assembly, And Thermosensitivity Of Amphiphilic Poegma-Pdms-Poegma Triblock Copolymers

Polymersomes from Dual Responsive Block Copolymers: Drug Encapsulation by Heating and Acid-Triggered Release